California asks FDA to undo limits on abortion pill mifepristone amid RFK Jr. scrutiny
California and the other three states, the US Food and Pharmaceutical Administration, on Thursday, to alleviate the restrictions on the abortion pill Mifepristone, specifying the proven security record of the drug and petition to defend that the boundaries are unnecessary.
“Pharmaceuticals, a life line for millions of women who need to access critical health services, especially low-income women and those who live in rural and inadequate service areas,” California Atty said. Massachusetts, New York and New Jersey Chief Public Prosecutors who opened the petition with General Rob Bonda.
The petition said Kennedy’s FDA manager Martin Makary ordered Martin Makary to make Mifepristone and labeling requirements to make a “complete review ..
According to experts, the drug that can be taken by mail has been taken safely in the US market for 25 years and by millions of Americans. The Supreme Court is the most common method of terminating pregnancy in the United States after overturning Wade against Roe and Wade in 2022.
The Supreme Court approved access to the drug for early pregnancies in accordance with FDA regulations last year, but remained a target of anti -Cantiabtion conservatives. The Trump administration gave Kennedy Broadeway to shake the American medicine in the “Make America again healthy” poster, and Kennedy quickly listed medical professionals using suspicious science – And even fake quotes – Questioning vaccine regimes and research And long -term public health measures.
Kennedy at the Senate hearing, A flawed report In order to question Mifepriston’s security, the report was pushed to the report by the Antiaboltion groups called “worrying ında and was published in any refereed magazine.
Kennedy, “frankly, at least shows that the label should be changed,” he said.
Senator Josh Hawley (R-MO.) On Monday Sent a letter Makary wrote to X, in which Makary wrote with the “professional career scientists in the FDA with the“ Professional Career Scientists ”.
Makary, the ongoing case around the drug can not provide additional information, he said.
States, their 54 -page petition“Since the latest regulatory actions that would change the conclusion that the FDA remained extremely safe and effective, a new scientific data has not emerged” and “Mifepriston’s frequently mentioned studies to weaken the comprehensive security records were criticized, withdrawing, or both.
The Democrats overthrew Kennedy’s criticism of Mifepristone politically and unquestionably.
Gov. “This is another attack on women’s freedom of reproduction and scientifically reviewed health services,” Gavin Newsom said one day after Kennedy’s Senate expression. “California will continue to help everyone make their own medical decisions and make Mifepristone exist for those who need it.”
Bonda said on Thursday that Mifepristone’s FDA’s FDA’s FDA’s FDA is “medically unjust ve and provides“ overload to the whole health system of the country ”.
Mifepriston said that “people allow them to take reproductive care as early as possible when they are the safest, cheapest, cheapest and at least invasive ,,“ offers lower serious complications risks than taking Tylenol ”and long security records are supported by science and cannot be erased at the door of Trump.
FDA He said before Less than 0.5% of women who receive drugs are “serious adverse reactions” and deaths are extremely rare.
The Risk Assessment Program requires prescriptions to add their names to the lists of national and local abortion, which can be a deterrent for doctors who are given security threats, and pharmacies to comply with complex monitoring, shipping and reporting requirements that may be deterrent in transporting the drug.
In addition, it requires patients to sign the forms they prove what they want to finish. [their] Pregnancy, Bond said Bonda, for women who use the drug after a miscarriage – one of their common uses – or can be a deterrent in criminal penalties for women looking for certain abortion care.
According to federal laws, the requirements should take a certain risk of a drug and cannot be “extremely burdensome ve on patients and the application to MİFEPRISTON“ cannot meet this standard ”.
States, states’ petition is not a case, but a regulatory demand for the reversal of the FDA, he said.
If the FDA is not going to do this throughout the country, the state, which has given four petitions, said that Bonda’s office has a solid state laws that provide safe prescription, meticulously informed consent and professional accountability ”.
